In terms of the TAT dose for immune infiltration, we previously found that, compared with 2 higher doses, the lowest dose (3.7 kBq) of 225Ac-DOTA-M5A increased tumor infiltration of CD8+ T cells (19). This evidence concerns the gene CD8A and neoplasm.